![](https://media.americanpharmaceuticalreview.com/m/28/article/614121.jpg)
Health Canada Grants Marketing Authorization for TRIKAFTA® for Cystic Fibrosis
Vertex Pharmaceuticals Incorporated (announced that Health Canada has granted Marketing Authorization for the expanded use of PrTRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of cystic fibrosis (CF) in patients aged 2 …